Answers are grounded in this paper and cite their sources.
This research demonstrates how CCL19 enhances immune cell recruitment in DNA vaccines, suggesting improved cancer therapies.
CCL19 serves as an effective APC-targeting unit when fused to neoantigens, maintaining chemotactic and signaling properties that improve DNA vaccine immunogenicity and tumor control. This chemokine-mediated strategy offers a flexible approach to increase DNA vaccine potency with broad potential applications in cancer immunotherapies and beyond.
No takes yet. Share an insight, caveat, or question.
Barrio-Calvo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: